Product Series
Heparin Binding Protein
COVID-19 Antigen Rapid Test
·Sample type: Anterior Nasal Swab ·Non-invasive, painless sample collection ·High sensitivity & specificity. Can be used for early screening. Facilitates patient treatment decisions quickly; ·Suitable for multiple scenarios: medical institution testing; screening before resumption of work and school, continuous monitoring, etc. ·One-step method, easy to operate, reducing missed or false inspections caused by operator errors; ·All necessary reagent provided & No equipment required; ·Ti...
COVID-19 Antigen Rapid Test
Sample type: Nasopharyngeal Swab ŸHigh sensitivity & specificity. Can be used for early screening. Facilitates patient treatment decisions quickly; ŸSuitable for multiple scenarios: medical institution testing; screening before resumption of work and school, continuous monitoring, etc. ŸOne-step method, easy to operate, reducing missed or false inspections caused by operator errors; ŸAll necessary reagent provided & No equipment required; ŸTime saving procedures, results are available...
3 in 1 Antigen Rapid Test
About Us
Founded in December 2010, Joinstar Biomedical Technology Co., Ltd. (hereinafter referred to as Joinstar) is a national high-tech enterprise specializing in the R&D, production, and marketing of in vitro diagnosis (IVD) products. In addition, it has been awarded various honors, including National Key “Little Giant” Enterprise in the First Batch, Zhejiang Provincial Hidden Champion Enterprise, Soonicorn, Key Pre-IPO Enterprise in Hangzhou, Model Collective in Hangzhou, Winner of the Second Prize of Zhejiang Provincial Science and Technology Progress Award, and Key Enterprise for Pandemic Prevention and Control in Zhejiang.
News
-
ECCMID 2023 | JOINSTAR INFECTION DISEASE BIOMARKERS SHOWCASED
Joinstar attended the prestigious 33rd European Congress of Clinical Microbiology & Infectious Diseases, where the experts from all over the world gathered in Copenhagen. A key feature of the Congress was Sepsis and related inflammatory diseases in terms of their diagnosis and management. This allowed Joinstar to present its panel of automated rapid sepsis tests including its patented Heparin Binding Protein assay. There was considerable interest in these products and delegates from over 30 countries visited the Joinstar booth who were given a demonstration on...
-
ISICEM 2023 (Belgium) JOINSTAR RAPID HBP TEST SHOWCASED
At this International Critical Care meeting the Jet-iStar platforms (JS 800 and JS800 Plus) and the full range of Point-of-Care assays were presented with a special focus on Heparin Binding Protein (HBP), a novel patented biomarker which has been shown to play a key role in the management of Sepsis patients. Detailed presentations on the Joinstar product portfolio were made to delegates from over 20 countries and the interest from Clinicians in learning more about HBP was very encouraging and showed that there is a clear need for early biomarker(s) in Sepsis, a life-threatening disease. Of ...
